These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 31487529)

  • 21. Mesenchymal stem cells as a treatment for multiple sclerosis: a focus on experimental animal studies.
    Lotfy A; Ali NS; Abdelgawad M; Salama M
    Rev Neurosci; 2020 Jan; 31(2):161-179. PubMed ID: 31605598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transplantation of placenta-derived mesenchymal stem cells in the EAE mouse model of MS.
    Fisher-Shoval Y; Barhum Y; Sadan O; Yust-Katz S; Ben-Zur T; Lev N; Benkler C; Hod M; Melamed E; Offen D
    J Mol Neurosci; 2012 Sep; 48(1):176-84. PubMed ID: 22638856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current advances in stem cell therapy in the treatment of multiple sclerosis.
    Zolfaghari Baghbadorani P; Rayati Damavandi A; Moradi S; Ahmadi M; Bemani P; Aria H; Mottedayyen H; Rayati Damavandi A; Eskandari N; Fathi F
    Rev Neurosci; 2023 Aug; 34(6):613-633. PubMed ID: 36496351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis.
    Constantin G; Marconi S; Rossi B; Angiari S; Calderan L; Anghileri E; Gini B; Bach SD; Martinello M; Bifari F; Galiè M; Turano E; Budui S; Sbarbati A; Krampera M; Bonetti B
    Stem Cells; 2009 Oct; 27(10):2624-35. PubMed ID: 19676124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential Therapeutic Features of Human Amniotic Mesenchymal Stem Cells in Multiple Sclerosis: Immunomodulation, Inflammation Suppression, Angiogenesis Promotion, Oxidative Stress Inhibition, Neurogenesis Induction, MMPs Regulation, and Remyelination Stimulation.
    Abbasi-Kangevari M; Ghamari SH; Safaeinejad F; Bahrami S; Niknejad H
    Front Immunol; 2019; 10():238. PubMed ID: 30842772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesenchymal stem cells as treatment for MS - progress to date.
    Uccelli A; Laroni A; Freedman MS
    Mult Scler; 2013 Apr; 19(5):515-9. PubMed ID: 23124791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Therapeutic Mechanisms of Mesenchymal Stem Cells in MS-A Review Focusing on Neuroprotective Properties.
    Gavasso S; Kråkenes T; Olsen H; Evjenth EC; Ytterdal M; Haugsøen JB; Kvistad CE
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesenchymal Stem Cells in Multiple Sclerosis: Recent Evidence from Pre-Clinical to Clinical Studies.
    Gugliandolo A; Bramanti P; Mazzon E
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33212873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesenchymal stem cells expressing vasoactive intestinal peptide ameliorate symptoms in a model of chronic multiple sclerosis.
    Cobo M; Anderson P; Benabdellah K; Toscano MG; Muñoz P; García-Pérez A; Gutierrez I; Delgado M; Martin F
    Cell Transplant; 2013; 22(5):839-54. PubMed ID: 23031550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications.
    Yi T; Song SU
    Arch Pharm Res; 2012 Feb; 35(2):213-21. PubMed ID: 22370776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human Adipose Stromal/Stem Cells from Obese Donors Show Reduced Efficacy in Halting Disease Progression in the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis.
    Strong AL; Bowles AC; Wise RM; Morand JP; Dutreil MF; Gimble JM; Bunnell BA
    Stem Cells; 2016 Mar; 34(3):614-26. PubMed ID: 26700612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Harnessing the therapeutic potential of mesenchymal stem cells in multiple sclerosis.
    Darlington PJ; Boivin MN; Bar-Or A
    Expert Rev Neurother; 2011 Sep; 11(9):1295-303. PubMed ID: 21864075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A consensus statement addressing mesenchymal stem cell transplantation for multiple sclerosis: it's time!
    Siatskas C; Payne NL; Short MA; Bernard CC
    Stem Cell Rev Rep; 2010 Dec; 6(4):500-6. PubMed ID: 20665128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adipose-derived mesenchymal stem cells modulate the immune response in chronic experimental autoimmune encephalomyelitis model.
    Shalaby SM; Sabbah NA; Saber T; Abdel Hamid RA
    IUBMB Life; 2016 Feb; 68(2):106-15. PubMed ID: 26757144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-based therapeutic strategies for multiple sclerosis.
    Scolding NJ; Pasquini M; Reingold SC; Cohen JA; ; ;
    Brain; 2017 Nov; 140(11):2776-2796. PubMed ID: 29053779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesenchymal Stromal/Stem Cells Do Not Ameliorate Experimental Autoimmune Encephalomyelitis and Are Not Detectable in the Central Nervous System of Transplanted Mice.
    Abramowski P; Krasemann S; Ernst T; Lange C; Ittrich H; Schweizer M; Zander AR; Martin R; Fehse B
    Stem Cells Dev; 2016 Aug; 25(15):1134-48. PubMed ID: 27250994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 17β-Estradiol enhances the efficacy of adipose-derived mesenchymal stem cells on remyelination in mouse model of multiple sclerosis.
    Ragerdi Kashani I; Hedayatpour A; Pasbakhsh P; Kafami L; Atlasi N; Pirhajati Mahabadi V; Mamoudi R; Baazm M
    Acta Med Iran; 2012; 50(12):789-97. PubMed ID: 23456519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mesenchymal stem cells and induced pluripotent stem cells as therapies for multiple sclerosis.
    Xiao J; Yang R; Biswas S; Qin X; Zhang M; Deng W
    Int J Mol Sci; 2015 Apr; 16(5):9283-302. PubMed ID: 25918935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opportunities and challenges: mesenchymal stem cells in the treatment of multiple sclerosis.
    Zhang Y; Gu J; Wang X; Li L; Fu L; Wang D; Wang X; Han X
    Int J Neurosci; 2023 Dec; 133(9):1031-1044. PubMed ID: 35579409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Efficacy of Mesenchymal Stem Cell Therapies in Rodent Models of Multiple Sclerosis: An Updated Systematic Review and Meta-Analysis.
    He J; Huang Y; Liu J; Lan Z; Tang X; Hu Z
    Front Immunol; 2021; 12():711362. PubMed ID: 34512632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.